Cargando…
Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease
Excessive insulin signaling through the insulin receptor (IR) may play a role in the pathogenesis of diet-induced metabolic disease, including obesity and type 2 diabetes. Here we investigate whether heterozygous impairment of insulin receptor (IR) expression limited to peripheral, i.e. non-CNS, tis...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190665/ https://www.ncbi.nlm.nih.gov/pubmed/32350271 http://dx.doi.org/10.1038/s41467-020-15623-z |
_version_ | 1783527729403002880 |
---|---|
author | Merry, Troy L. Hedges, Chris P. Masson, Stewart W. Laube, Beate Pöhlmann, Doris Wueest, Stephan Walsh, Michael E. Arnold, Myrtha Langhans, Wolfgang Konrad, Daniel Zarse, Kim Ristow, Michael |
author_facet | Merry, Troy L. Hedges, Chris P. Masson, Stewart W. Laube, Beate Pöhlmann, Doris Wueest, Stephan Walsh, Michael E. Arnold, Myrtha Langhans, Wolfgang Konrad, Daniel Zarse, Kim Ristow, Michael |
author_sort | Merry, Troy L. |
collection | PubMed |
description | Excessive insulin signaling through the insulin receptor (IR) may play a role in the pathogenesis of diet-induced metabolic disease, including obesity and type 2 diabetes. Here we investigate whether heterozygous impairment of insulin receptor (IR) expression limited to peripheral, i.e. non-CNS, tissues of adult mice impacts the development of high-fat diet-induced metabolic deterioration. While exhibiting some features of insulin resistance, PerIRKO(+/−) mice display a hepatic energy deficit accompanied by induction of energy-sensing AMPK, mitochondrial biogenesis, PPARα, unexpectedly leading to protection from, and reversal of hepatic lipid accumulation (steatosis hepatis, NAFLD). Consistently, and unlike in control mice, the PPARα activator fenofibrate fails to further affect hepatic lipid accumulation in PerIRKO(+/−) mice. Taken together, and opposing previously established diabetogenic features of insulin resistance, incomplete impairment of insulin signaling may mimic central aspects of calorie restriction to limit hepatic lipid accumulation during conditions of metabolic stress. |
format | Online Article Text |
id | pubmed-7190665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-71906652020-05-01 Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease Merry, Troy L. Hedges, Chris P. Masson, Stewart W. Laube, Beate Pöhlmann, Doris Wueest, Stephan Walsh, Michael E. Arnold, Myrtha Langhans, Wolfgang Konrad, Daniel Zarse, Kim Ristow, Michael Nat Commun Article Excessive insulin signaling through the insulin receptor (IR) may play a role in the pathogenesis of diet-induced metabolic disease, including obesity and type 2 diabetes. Here we investigate whether heterozygous impairment of insulin receptor (IR) expression limited to peripheral, i.e. non-CNS, tissues of adult mice impacts the development of high-fat diet-induced metabolic deterioration. While exhibiting some features of insulin resistance, PerIRKO(+/−) mice display a hepatic energy deficit accompanied by induction of energy-sensing AMPK, mitochondrial biogenesis, PPARα, unexpectedly leading to protection from, and reversal of hepatic lipid accumulation (steatosis hepatis, NAFLD). Consistently, and unlike in control mice, the PPARα activator fenofibrate fails to further affect hepatic lipid accumulation in PerIRKO(+/−) mice. Taken together, and opposing previously established diabetogenic features of insulin resistance, incomplete impairment of insulin signaling may mimic central aspects of calorie restriction to limit hepatic lipid accumulation during conditions of metabolic stress. Nature Publishing Group UK 2020-04-29 /pmc/articles/PMC7190665/ /pubmed/32350271 http://dx.doi.org/10.1038/s41467-020-15623-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Merry, Troy L. Hedges, Chris P. Masson, Stewart W. Laube, Beate Pöhlmann, Doris Wueest, Stephan Walsh, Michael E. Arnold, Myrtha Langhans, Wolfgang Konrad, Daniel Zarse, Kim Ristow, Michael Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title_full | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title_fullStr | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title_full_unstemmed | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title_short | Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
title_sort | partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190665/ https://www.ncbi.nlm.nih.gov/pubmed/32350271 http://dx.doi.org/10.1038/s41467-020-15623-z |
work_keys_str_mv | AT merrytroyl partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT hedgeschrisp partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT massonstewartw partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT laubebeate partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT pohlmanndoris partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT wueeststephan partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT walshmichaele partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT arnoldmyrtha partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT langhanswolfgang partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT konraddaniel partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT zarsekim partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease AT ristowmichael partialimpairmentofinsulinreceptorexpressionmimicsfastingtopreventdietinducedfattyliverdisease |